$PIRS hope you people listened and bought PRVB. When I first recommended this company, on this Board, it was $9.77/share. Forget the fact PRVB will be irradecating Type 1 D, forget the fact the FDA believes so strongly in the drug - Teplizumab - they elected to NOT need a phase III trial in the at risk population, and forget the fact all mgmt has been heavy buying their own stock heavily - the company has only 17 employees saving every penny possible of shareholder dollars. Insider buying: openinsider.com/screener?s=... PIRS has 130 employees destroying shareholder dollars for no reason whatsoever - none are needed. Yoder is making 2.6 million versus my CEO making all in (base & bonus) - $650,000. Lastly, PIRS has been in business since 2001 - 19 years of nothing. PRVB has been in business since 2017 with their first approval coming potentially within 2020 - this year. Drop the zero and get with a hero!